Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC.ACHV · Entity 5072 | President & CMO | September 04, 2025 | September 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACHIEVE LIFE SCIENCES, INC.
Report date September 04, 2025 · Filed September 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,585 |
Ending reported balance
After 2025-09-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-09-04 · Exercise / conversion · Acquired 110,000 · Balance 143,214 F1: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Row 2 · 2025-09-04 · Sale · Disposed 27,629 · Balance 115,585 F2: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Performance Restricted Stock Unit (PRSU)SEC Table II · derivative / convertible security · Expires 2028-01-22 | Direct | 0 |
Reported balance
After 2025-09-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-09-04 · Exercise / conversion · Disposed 84,000 · Balance 0 F4: Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F6: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. |
| Performance Restricted Stock Unit (PRSU)SEC Table II · derivative / convertible security · Expires 2035-01-28 | Direct | 104,000 |
Reported balance
After 2025-09-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-09-04 · Exercise / conversion · Disposed 26,000 · Balance 104,000 F7: Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F8: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
F2: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs.
F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
F5: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F6: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.
F7: Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors.
F8: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2025 Filed Sep 8, 2025 20:51 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113588 · ownership.xml · derivative · entry 4 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Stock · 26,000 shares Expires 2035-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Represents PRSUs previously reported on January 30, 2025 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F8 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest ranges from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:51 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113588 · ownership.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 84,000 shares Expires 2028-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Represents PRSUs previously reported on January 24, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. F5 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F6 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:51 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | SaleCommon Stock | 27,629 | $2.77 | $76,532.33 |
DisclosureSEC source: 0000950170-25-113588 · ownership.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,585 F2 · shares: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the PRSUs. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.68 to $2.88 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 20:51 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-113588 · ownership.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:50 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-011156 · ownership.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2035-01-28 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuer's common stock that may ultimately vest range from 0% to 100% of the number of the PRSUs initially granted, subject to certain milestones being met during the measurement period. Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:07 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantCommon Stock | 2,660 | $3.67 | $9,762.20 |
DisclosureSEC source: 0000950170-24-099082 · ownership.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,214 F1 · kind: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:35 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046974 · ownership.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,250 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:35 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 3,957 | $4.51 | $17,846.07 |
DisclosureSEC source: 0000950170-24-046974 · ownership.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,554 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 20:35 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046974 · ownership.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 36,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001209191-24-002194 · doc4.xml · derivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 36,000 shares Expires 2034-01-22 F3 · derivative.exercise_date: The options vest one-third on the first anniversary of January 22, 2024 and thereafter in monthly installments over 24 months. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002194 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2028-01-22 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones being met. The PRSUs will lapse in full if achievement of at least one of the milestones is not met. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:54 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026321 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2025-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:54 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 609 | $8.29 | $5,048.61 |
DisclosureSEC source: 0001209191-23-026321 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,261 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 28, 2023 Filed May 1, 2023 21:54 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-026321 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,870 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 20:14 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025381 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,250 Underlying: Common Stock · 16,250 shares Expires 2026-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 20:14 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 4,819 | $6.80 | $32,769.20 |
DisclosureSEC source: 0001209191-23-025381 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,362 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 20:14 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 16,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025381 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 20:27 UTC Amendment | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 3,811 | $6.80 | $25,914.80 |
DisclosureSEC source: 0001209191-23-025534 · doc4a.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,370 F1 · shares: This amended Form 4 is filed to correct an administrative error which applied additional taxes and misreported the number of shares of common stock withheld by the issuer to satisfy the tax liability in connection with the settlement of performance restricted stock units. 3,811 shares were withheld instead of 4,819. F2 · balance_after: The number of shares beneficially owned by the reporting person increased from 15,362 shares to 16,370 shares. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 21:47 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $4.90 | $0.00 |
DisclosureSEC source: 0001209191-23-005286 · doc4.xml · derivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-01-25 F3 · derivative.exercise_date: The options vest one-third on the first anniversary of January 25, 2023 and thereafter in monthly installments over 24 months. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 21:47 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-005286 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2025-12-31 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the award agreement governing the PRSU, the number of underlying shares of the Issuers common stock that may ultimately vest range from 0% to 100% of the number of PRSUs initially granted, subject to certain milestones being met during the measurement period that begins on January 3, 2023 and ends on December 31, 2025. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 20:39 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantCommon Stock | 1,817 | $4.37 | $7,940.29 |
DisclosureSEC source: 0001209191-22-046647 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,931 F1 · kind: Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 20:43 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionPerformance Restricted Stock Unit (PRSU) · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026283 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2025-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 20:43 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 609 | $7.43 | $4,524.87 |
DisclosureSEC source: 0001209191-22-026283 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,114 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 20:43 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026283 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:33 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 32,500 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001209191-22-001711 · doc4.xml · derivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2032-01-03 F3 · derivative.exercise_date: The options vest one-third on the first anniversary of January 3, 2022 and thereafter in monthly installments over 24 months. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:33 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001711 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2026-01-03 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The PRSUs will lapse in full if achievement of such milestone is not met. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:09 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 68 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052573 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 1, 2017 and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:09 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 21 | $6.81 | $143.01 |
DisclosureSEC source: 0001209191-21-052573 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223 F2 · shares: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of RSUs. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 21:09 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 68 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-052573 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · Director · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:29 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001209191-21-005883 · doc4.xml · derivative · entry 2 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-01-26 F3 · derivative.exercise_date: The options vest 25% on the first anniversary of January 26, 2021 and thereafter in monthly installments over 36 months. Read SEC document |
| January 26, 2021 Filed Jan 28, 2021 21:29 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantPerformance Restricted Stock Unit (PRSU) · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-005883 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2025-01-26 F1 · derivative.exercise_price: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. F2 · derivative.exercise_date: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The PRSUs will lapse in full if achievement of such milestone is not met. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:40 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $10.36 | $0.00 |
DisclosureSEC source: 0001209191-20-059129 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · President & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2030-11-16 F1 · derivative.exercise_date: Pursuant to the terms of the options 50% of the total shares underlying the option vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone. The options will lapse in full if achievement of such milestone is not met. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:25 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047494 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68 Underlying: Common Stock · 69 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F5 · shares: This RSU was initially reported as covering 54,800 shares and was adjusted on May 23, 2018 to reflect a 1-for-10 split, and which number has been adjusted to reflect the Stock Split. F6 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 1, 2017 and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:25 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 33 | $8.95 | $295.35 |
DisclosureSEC source: 0001209191-20-047494 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176 F3 · shares: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:25 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047494 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. F2 · balance_after: On July 31, 2020, the Issuer effected a 1-for-20 split of its common stock (the "Stock Split") resulting in a decrease of the reporting person's ownership by 2,661 shares of common stock. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 21:58 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.56 | $0.00 |
DisclosureSEC source: 0001209191-20-005567 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2030-01-28 F1 · derivative.exercise_date: The options vest 25% on the first anniversary of January 28, 2020 and thereafter in monthly installments over 36 months. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 21:15 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046194 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740 Underlying: Common Stock · 1,370 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 1, 2017 and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 21:40 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001209191-19-006168 · doc4.xml · derivative · entry 2 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-01-29 F2 · derivative.exercise_date: Pursuant to the terms of the options 25% of the total shares underlying the option vest on the achievement of a performance-based milestone, and 75% vest in monthly installments over 24 months commencing one month from achievement of such milestone. The options will lapse in full if achievement of such milestone is not met by mid-2019 Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 21:40 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001209191-19-006168 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2029-01-29 F1 · derivative.exercise_date: The options vest 25% on the first anniversary of January 29, 2019 and thereafter in monthly installments over 36 months. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 22:32 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-004325 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42 shares Expires 2019-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement. F4 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015; and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 22:32 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 13 | $1.16 | $15.08 |
DisclosureSEC source: 0001209191-19-004325 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,839 F2 · shares: Represents shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the reporting person. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 22:32 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-004325 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,852 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 20:42 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | GrantStock Option (right to buy) · Derivative | 37,000 | $0.00 Strike: $2.56 | $0.00 |
DisclosureSEC source: 0001209191-18-051902 · doc4.xml · derivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 37,000 shares Expires 2028-09-20 F1 · derivative.exercise_date: The options vest in monthly installments over 48 months commencing one month from September 20 2018. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046838 · doc4.xml · derivative · entry 6 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,110 Underlying: Common Stock · 1,370 shares Expires 2021-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F13 · shares: This RSU was previously reported as covering 54,800 shares, which number was adjusted to reflect the Stock Split. F14 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of August 1, 2017 and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 43 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046838 · doc4.xml · derivative · entry 5 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42 Underlying: Common Stock · 43 shares Expires 2019-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F11 · shares: This RSU was previously reported as covering 852 shares, which number was adjusted to reflect the Stock Split. F12 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2015 and (ii) the first day thereafter during which the issuer's trading window is open. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046838 · doc4.xml · derivative · entry 4 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F9 · shares: This RSU was previously reported as covering 454 shares, which number was adjusted to reflect the Stock Split. F10 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of June 12, 2014 and (ii) the first day thereafter during which the issuer's trading window is open. F8 · derivative.expiration_date: The RSUs expire 30 days from the date they vest. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 28 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046838 · doc4.xml · derivative · entry 3 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement. F6 · shares: This RSU was previously reported as covering 284 shares, which number was adjusted to reflect the Stock Split. F7 · derivative.exercise_date: Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of (i) each anniversary of January 1, 2014 and (ii) the first day thereafter during which the issuer's trading window is open. F8 · derivative.expiration_date: The RSUs expire 30 days from the date they vest. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 472 | $2.78 | $1,312.16 |
DisclosureSEC source: 0001209191-18-046838 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,810 F3 · shares: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.77 to $2.815 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:55 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Exercise / conversionCommon Stock | 1,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046838 · doc4.xml · nonDerivative · entry 1 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II. F2 · balance_after: On May 23 2018, the Issuer effected a 1-for-10 split of its common stock (the "Stock Split") resulting in a decrease of the reporting person's ownership by 7,179 shares of common stock. Read SEC document |
| August 13, 2018 Filed Aug 15, 2019 21:15 UTC | ACHIEVE LIFE SCIENCES, INC. ACHV · Entity 5072 | Tax withholdingCommon Stock | 408 | $1.88 | $767.04 |
DisclosureSEC source: 0001209191-19-046194 · doc4.xml · nonDerivative · entry 2 JACOBS CINDY · CIK 0001229762 · EVP, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,801 F2 · shares: Represents shares of common stock that have been sold by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.